Loading chart…
PRE-MARKET
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, eye drops, dry powder suspension, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, gynaecology, nephrology, and pain management.
Ajanta Pharma Limited (AJANTPHARM) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The AJANTPHARM share price is ₹3,344.00 (+1.10% today), with a market capitalisation of ₹418B and a price-to-earnings (P/E) ratio of 33.1. MarketRipple tracks the AJANTPHARM investment thesis, the ripple-chain impact of market events on Ajanta Pharma Limited, and the Healthcare sector outlook.
Open
₹3,338.20
High
₹3,410.40
Low
₹3,280.00
Prev. Close
₹3,307.70
52W High
₹3,796.00
52W Low
₹2,445.80
Day range
₹3,280.00–₹3,410.40
52-week range
₹2,445.80–₹3,796.00
Volume
144K
P/E
33.1
ROE
27.5%
D/E
0.06
Margin
20.3%
Ajanta Pharma Limited (NSE: AJANTPHARM) is currently trading at ₹3,344.00 (+1.10%).
Ajanta Pharma Limited's market capitalization is ₹418B.
Ajanta Pharma Limited's price-to-earnings (P/E) ratio is 33.1.
Ajanta Pharma Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Ajanta Pharma Limited currently reads positive, based on 13 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.